CRRTF and CTX Related Headlines
Go Back- Crescita Therapeutics Inc. Announces Closing of Arrangement
- Crescita Therapeutics Inc. Announces Final Consideration Payable to Shareholders Pursuant to Arrangement with ClinActiv
- Crescita Therapeutics Inc. Obtains Final Order Approving Plan of Arrangement
- Crescita shareholders approve $0.80 per share acquisition by ClinActiv
- Crescita Obtains Shareholder Approval To Be Acquired By ClinActiv Holdings
- Crescita Reports First Quarter 2026 Results
- Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings
- Crescita Reports Q4 and Fiscal 2025 Results
- Crescita agrees to $0.80-per-share acquisition by ClinActiv Holdings
- Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium
- Crescita Reports Third Quarter 2025 Results
- Crescita Reports Second Quarter 2025 Results
- Crescita Therapeutics (CTX) announce voting results from AGM
- Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
CRRTF and CTX Related Press Releases
Go Back- Crescita Therapeutics Inc. Announces Closing of Arrangement
- Crescita Therapeutics Inc. Announces Final Consideration Payable to Shareholders Pursuant to Arrangement with ClinActiv
- Crescita Therapeutics Inc. Obtains Final Order Approving Plan of Arrangement
- Crescita Obtains Shareholder Approval To Be Acquired By ClinActiv Holdings
- Crescita Reports First Quarter 2026 Results
- Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings
- Crescita Reports Q4 and Fiscal 2025 Results
- Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium
- Crescita Reports Third Quarter 2025 Results
- Crescita Reports Second Quarter 2025 Results
- Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

